EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

Main Article Content

Eduardo Magalhães Rego
National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology/Hematology, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo,

Rafael Henriques Jácomo
Department of Internal Medicine, Medical School, University of Brasília, Brazil

Keywords

Leukemia, Acute Promylocytic Leukemia, Latin America, Epidemiology

Abstract

Distinct epidemiological characteristics have been described in Acute Promielocytic Leukemia (APL). Populations from Latin America have a higher incidence of APL and in some geographic areas a distinct distribution of the PML-RARA isoforms is present. Here, we review the main differences in APL epidemilogy in Latin America as well as treatment outcomes.

Downloads

Download data is not yet available.


Abstract 2228
PDF Downloads 735
HTML Downloads 2436

Article Sidebar

PDF HTML
Published
Oct 24, 2011
DOI https://doi.org/10.4084/mjhid.2011.049

Article Details

How to Cite

Rego, E. M. and Jácomo, R. H. (2011) “EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA”, Mediterranean Journal of Hematology and Infectious Diseases, 3(1), p. e2011049. doi: 10.4084/mjhid.2011.049.
Issue
Vol. 3 No. 1 (2011): Reviews, Articles, Case Reports and Letters
Section
Review Articles

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 
Author Biography

Eduardo Magalhães Rego, National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology/Hematology, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo,

    1   Corresponding author: Eduardo Magalhães Rego, Division of Oncology/Hematology, Department of Internal Medicine; Medical School of Ribeirão Preto, University of São Paulo, Av. Bandeirantes 3900, CEP 14049-900, Ribeirão Preto, SP, Brazil. Phone: (55)(16) 36022888, Fax: (55)(16) 36336695. Email: emrego@hcrp.fmrp.usp.br